CAPTRUST Financial Advisors’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.7K Buy
16,994
+3,880
+30% +$6.89K ﹤0.01% 2941
2025
Q4
$18.6K Buy
13,114
+2,352
+22% +$3.43K ﹤0.01% 2717
2025
Q3
$17.6K Sell
10,762
-1,310
-11% -$1.46K ﹤0.01% 2610
2025
Q2
$8.83K Buy
12,072
+904
+8% +$781 ﹤0.01% 2500
2025
Q1
$9.01K Sell
11,168
-317
-3% -$365 ﹤0.01% 2341
2024
Q4
$15.8K Sell
11,485
-7,304
-39% -$8.19K ﹤0.01% 2275
2024
Q3
$19.5K Buy
18,789
+7,393
+65% +$10.1K ﹤0.01% 2261
2024
Q2
$19.7K Buy
11,396
+889
+8% +$1.79K ﹤0.01% 2174
2024
Q1
$25.1K Buy
+10,507
New +$25.9K ﹤0.01% 2111
2023
Q4
Sell
-42,607
Closed -$159K 2692
2023
Q3
$159K Buy
42,607
+18,862
+79% +$87.1K ﹤0.01% 2353
2023
Q2
$101K Buy
+23,745
New +$140K ﹤0.01% 2375
2022
Q3
Sell
-2,725
Closed -$20K 2406
2022
Q2
$20K Buy
2,725
+321
+13% +$2.79K ﹤0.01% 3369
2022
Q1
$31K Buy
2,404
+2,250
+1,461% +$28.6K ﹤0.01% 3116
2021
Q4
$2K Buy
154
+29
+23% +$507 ﹤0.01% 4392
2021
Q3
$2K Sell
125
-513
-80% -$7.52K ﹤0.01% 4240
2021
Q2
$9K Buy
638
+415
+186% +$5.88K ﹤0.01% 3587
2021
Q1
$3K Buy
223
+98
+78% +$1.66K ﹤0.01% 3895
2020
Q4
$2K Buy
+125
New +$2.23K ﹤0.01% 3091
2020
Q3
Sell
-2,000
Closed -$36K 3069
2020
Q2
$36K Buy
+2,000
New +$33.9K ﹤0.01% 1736

Other funds holding CHRS